Cora NelsonOn September 23, 2026, former Tennessee Titans running back Chris Johnson — the man who set the NFL single-season rushing record with 2,509 yards in 2009 — cannot speak without an eye-controlled device. Diagnosed with ALS at age 39 in May 2025, "CJ2K" recently told People magazine that the disease has stripped away nearly every form of daily independence in just 17 months. His wife, Brittany, now serves as his full-time caregiver.
From Record-Breaking Speed to Eye-Controlled Speech
Johnson played 10 NFL seasons with the Tennessee Titans (2008–2013), New York Jets (2014), and Arizona Cardinals (2015–2017). At his peak, he was considered one of the fastest players in professional football. By the end of the 2025 season, he was communicating through a speech-generating device he operates with his eyes.
His first symptom was weakness in his right hand — something Brittany initially suspected was a pinched nerve, a reasonable assumption after a decade of professional contact sport. Johnson described the progression as far faster than he ever imagined. Within 17 months of diagnosis, he requires a CPAP machine for breathing support and needs assistance with feeding, changing, and physical therapy stretches.
His doctors classify the case as "sporadic ALS" — meaning there is no family history of the disease. Johnson himself has publicly acknowledged the possible link between his football career and his illness.
ALS, or amyotrophic lateral sclerosis, is a progressive neurodegenerative disease that destroys the nerve cells controlling voluntary muscle movement. It is universally fatal. There is no cure. Two FDA-approved treatments — riluzole and edaravone — can slow the disease's progression, but both show their strongest benefit when introduced early.
NFL Players and ALS: The Data Is Stark
Johnson's case sits at the intersection of two alarming datasets.
A landmark study of 19,423 NFL players who played at least one regular season game between 1960 and 2019 found that professional football players face a 3.6-fold higher rate of ALS diagnosis compared to carefully matched controls from the general population. Nearly fourfold higher ALS mortality was also documented.
The data revealed a dose-response relationship: NFL players who eventually developed ALS had played an average of 7 seasons, compared to just 4.5 seasons for matched players who did not develop the disease. More time on the field correlated with greater risk. Thirty-eight confirmed ALS cases were identified within the cohort, with a mean diagnosis age of approximately 51 years.
Johnson's diagnosis at 39 places him among the younger cases in the literature — and illustrates how aggressive the disease can be when it presents early.
The football connection is not the only risk pathway. Military veterans, agricultural workers, and people with long-term exposure to heavy physical labor or certain environmental toxins have also shown elevated ALS rates across population studies. According to the National Institute of Neurological Disorders and Stroke (NINDS), approximately 5,000 Americans are diagnosed with ALS each year. Average survival after diagnosis ranges from 2 to 5 years, though some patients live significantly longer.
The Symptoms That Get Dismissed
The cruelest feature of ALS may be how well it disguises its earliest warning signs.
Unexplained weakness in one hand. Occasional muscle twitching (fasciculations) in an arm or leg. Difficulty gripping a coffee mug, buttoning a shirt, or opening a jar. Subtle slurring when speaking quickly. Fatigue in a limb during ordinary activities like typing or walking.
Each of these, in isolation, has dozens of benign explanations. A pinched nerve. Repetitive strain injury. Carpal tunnel syndrome. Dehydration. Vitamin B12 deficiency. Thyroid dysfunction. Stress. For someone with a history of intense physical activity — an athlete, a construction worker, a warehouse manager — the reflex is to attribute any unusual physical sensation to occupational wear and tear.
This is precisely why the average time from first ALS symptom to confirmed diagnosis is 12 to 18 months. Patients wait. Doctors rule out simpler explanations. Months pass. The disease advances.
A neurologist's diagnostic evaluation for suspected ALS typically involves electromyography (EMG) — which detects abnormal electrical patterns in muscle tissue — alongside nerve conduction studies, brain and spinal MRI to rule out structural causes, and blood panels to exclude metabolic and autoimmune conditions. Most of this workup can be completed within two to three specialist appointments.
The clinical threshold most neurologists recognize: if unexplained weakness in any limb persists for 4 to 6 weeks without improvement — particularly when accompanied by visible muscle twitching in the same area — a neurology referral is warranted immediately. Not a follow-up primary care appointment. A direct specialist consultation.
A Concrete Scenario: When Waiting Costs Months of Function
Consider Daniel, a 43-year-old former college football player now working as a project manager in Dallas. In July 2026, he notices his right hand trembling faintly when he reaches for his phone. He assumes overwork — his company is in the middle of a product launch, the hours have been brutal. He stretches, takes ibuprofen, sleeps more. Four weeks pass. The trembling becomes weakness. He struggles to open water bottles.
If Daniel contacts a neurologist at week 4 — when the weakness is still isolated to one hand — he enters the diagnostic pipeline at its most productive window. If EMG and nerve conduction studies confirm motor neuron involvement, he could begin riluzole within 8 to 10 weeks of that first specialist appointment. Clinical data shows riluzole extends median survival by approximately 2 to 3 months and delays the point at which patients require mechanical ventilation support.
If Daniel waits another 3 months — attributing symptoms to strain from overwork and old sports injuries — he risks starting treatment at a later stage of motor neuron loss. The drug's neuroprotective benefit is reduced when started later in disease progression. More critically, access to early-phase clinical trials, which currently represent the most promising frontier in ALS research, often requires patients to be in the first 18 to 24 months of confirmed diagnosis.
The functional arithmetic is significant: early intervention can mean 6 to 12 additional months of independent daily activity — driving, speaking without assistive technology, working, parenting.
The rule: if you have a history of contact sports, military service, or prolonged heavy physical labor, AND you notice new asymmetric weakness in any limb that persists longer than 4 weeks, do not attribute it to prior injuries without ruling out motor neuron involvement first.
What the Right Specialist Can Do
A neurologist's role in early ALS evaluation is not simply diagnosis — it is exclusion. The vast majority of patients referred for unexplained weakness will receive reassuring news: a treatable pinched nerve, a correctable nutritional deficiency, or a manageable inflammatory condition.
For the minority where the picture is more serious, being evaluated early means:
- Access to FDA-approved therapies at the stage when they slow progression most effectively
- Eligibility for clinical trials that require recent diagnosis (typically within 18–24 months of first symptom)
- Advance planning while cognitive function and communication remain intact — including legal, financial, and family arrangements that are far harder to manage when the disease has advanced
- Multidisciplinary care coordination from the outset, including respiratory therapy, occupational therapy, and nutrition support
Chris Johnson's openness about his diagnosis — describing the loss of independence and the speed of progression — has prompted many in the athletic and sports communities to look more carefully at neurological symptoms they previously ignored.
The lesson is transferable beyond sports. Any adult with a history of sustained physical occupational stress who notices progressive, asymmetric muscle weakness should treat that symptom as a specialist-level question — not a self-managed inconvenience.
This article is for informational purposes only and does not constitute medical advice. If you are experiencing neurological symptoms, consult a qualified healthcare provider.
The neurologists and medical experts on Expert Zoom can help you understand whether your symptoms warrant further investigation — and connect you with specialists who take occupational health history seriously in their evaluations.
